Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Renato Bassan, Monica Fumagalli, Sabina Chiaretti, Ernesta Audisio, Nicola Cascavilla, Stefania Paolini, Mario Delia, Elisa Cerqui, Caterina Micò, Francesco Fabbiano, Martina Canichella, Anna Maria Scattolin, Paola Perfetti, Francesca Paoloni, Mariangela Iodice, Antonella Vitale, Irene Della Starza, Paola Fazi, Marco Vignetti & Robin Foà. (2019) Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol. Leukemia & Lymphoma 60:14, pages 3482-3492.
Read now
Read now
Ibrahim Aldoss & Anthony S. Stein. (2018) Advances in adult acute lymphoblastic leukemia therapy. Leukemia & Lymphoma 59:5, pages 1033-1050.
Read now
Read now
Yoav Messinger, Jessica Boklan, John Goldberg, Steven G. DuBois, Javier Oesterheld, Oussama Abla, Alissa Martin, Joanna Weinstein & Nobuko Hijiya. (2017) Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemia. Pediatric Hematology and Oncology 34:4, pages 187-198.
Read now
Read now
E. Tavernier-Tardy, J. Cornillon, C. Molucon-Chabrot, J. Y. Cahn, F. Tinquaut, A. Bourmaud, D. Guyotat & X. Thomas. (2017) A phase 1/2 trial of lenalidomide and dexamethasone in adult patients with refractory/relapsed acute lymphoblastic leukemia. Hematology 22:4, pages 217-223.
Read now
Read now
Françoise Huguet. (2015) Dasatinib for acute lymphoblastic leukemia. Expert Opinion on Orphan Drugs 3:11, pages 1339-1356.
Read now
Read now
Articles from other publishers (18)
Maroua Slouma, Emna Hannech, Hela Ghedira, Rim Dhahri, Yasmine Khrifech, Raoudha Doghri & Imen Gharsallah. (2022) Osteoarticular manifestation of acute lymphoblastic leukemia in adults: a literature review. Clinical Rheumatology 42:2, pages 607-620.
Crossref
Crossref
Anita W. RijneveldBronno van der HoltOkke de WeerdtBart J. Biemond, Arjen A. van de LoosdrechtLotte E. van der WagenMar Bellido, Michel van GelderWalter J. F. M. van der Velden, Dominik SelleslagDaniëlle van Lammeren-VenemaConstantijn J. M. Halkes, Rob FijnheerViolaine HavelangeGeerte L. van SluisMarie-Cecile LegdeurDries DeerenAlain GadisseurHarm A. M. SinnigeDimitri A. BreemsAurélie JaspersOllivier LegrandWim E. TerpstraRinske S. BoersmaDominiek MazureAgnes TriffetLidwine W. TickKarolien BeelJohan A. MaertensH. Berna BeverlooMarleen Bakkus, Christa H. E. HomburgValerie de Haas, Vincent H. J. van der Velden & Jan J. Cornelissen. (2022) Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial. Blood Advances 6:4, pages 1115-1125.
Crossref
Crossref
Hetty E. Carraway, Yazeed Sawalha, Ivana Gojo, Min-Jung Lee, Sunmin Lee, Yusuke Tomita, Akira Yuno, Jackie Greer, B. Douglas Smith, Keith W. Pratz, Mark J. Levis, Steven D. Gore, Nilanjan Ghosh, Amy Dezern, Amanda L. Blackford, Maria R. Baer, Lia Gore, Richard Piekarz, Jane B. Trepel & Judith E. Karp. (2021) Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemia. Leukemia Research 110, pages 106707.
Crossref
Crossref
Josep‐Maria Ribera, Mireia Morgades, Eulàlia Genescà, Eduardo‐Cerello Chapchap, Pau Montesinos, Evelyn Acuña‐Cruz, Cristina Gil, Irene García‐Cadenas, Pere Barba, José González‐Campos, María‐Paz Queipo de Llano, Anna Torrent, Jordi Ribera, Isabel Granada, Teresa Bernal, Marina Díaz‐Beyá, María‐Luz Amigo, Rosa Coll, Mar Tormo, Ferran Vall‐llovera, Ignacio Gómez‐Centurión, María‐José Sánchez‐Sánchez, Beatriz Soria, Antonia Cladera, María‐Teresa Artola, Antoni Garcia‐Guiñon, Alberto Giménez‐Conca, María‐Lourdes Amador, Pilar Martínez‐Sánchez, Jesús‐Lorenzo Algarra, María‐Jesús Vidal, Natalia Alonso, Clara Maluquer, Laura Llorente, Raimundo García‐Boyero, Juana Ciudad, Evarist Feliu & Alberto Orfao. (2021) Outcomes and prognostic factors of adults with refractory or relapsed T‐cell acute lymphoblastic leukemia included in measurable residual disease‐oriented trials. Hematological Oncology 39:4, pages 529-538.
Crossref
Crossref
Gabriele Escherich, Udo Zur Stadt, Arndt Borkhardt, Dagmar Dilloo, Jörg Faber, Tobias Feuchtinger, Thomas Imschweiler, Norbert Jorch, Arnulf Pekrun, Irene Schmid, Franziska Schramm, Michael Spohn, Martin Zimmermann & Martin A Horstmann. (2021) Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group. Haematologica 107:5, pages 1026-1033.
Crossref
Crossref
Cumali YALÇIN, Fahir ÖZKALEMKAŞ, Vildan OZKOCAMAN, Tuba ERSAL, İbrahim Ethem PINAR, Bedrettin ORHAN, Ömer CANDAR & Rıdvan ALİ. (2021) Klofarabin Bazlı Tedavi Alan Relaps veya Refrakter Akut Lösemi Tanılı Hastaların Retrospektif DeğerlendirilmesiA Retrospective Study of Clofarabine Based Therapy in Patients With Relapsed or Refractory Acute Leukemia. Uludağ Üniversitesi Tıp Fakültesi Dergisi 47:2, pages 189-193.
Crossref
Crossref
Nitika, Jacob S. Blackman, Laura E. Knighton, Jade E. Takakuwa, Stuart K. Calderwood & Andrew W. Truman. (2020) Chemogenomic screening identifies the Hsp70 co-chaperone DNAJA1 as a hub for anticancer drug resistance. Scientific Reports 10:1.
Crossref
Crossref
Jacopo Peccatori, Sara Mastaglio, Fabio Giglio, Raffaella Greco, Roberto Crocchiolo, Francesca Patriarca, Barbara Forno, Sara Deola, Andrea Assanelli, Maria Teresa Lupo Stanghellini, Magda Marcatti, Marco Zecca, Sergio Cortelazzo, Renato Fanin, Franca Fagioli, Franco Locatelli & Fabio Ciceri. (2020) Clofarabine and Treosulfan as Conditioning for Matched Related and Unrelated Hematopoietic Stem Cell Transplantation: Results from the Clo3o Phase II Trial. Biology of Blood and Marrow Transplantation 26:2, pages 316-322.
Crossref
Crossref
Elena Pérez, Pedro A. Sánchez‐Murcia, Justin Jordaan, María Dolores Blanco, José Miguel Mancheño, Federico Gago & Jesús Fernández‐Lucas. (2018)
Enzymatic Synthesis of Therapeutic Nucleosides using a Highly Versatile Purine Nucleoside 2’‐DeoxyribosylTransferase from
Trypanosoma brucei
. ChemCatChem 10:19, pages 4406-4416.
Crossref
Crossref
Wafa Redjdal, Nada Ibrahim, Belkacem Benmerad, Mouad Alami & Samir Messaoudi. (2018) Convergent Synthesis of N,S-bis Glycosylquinolin-2-ones via a Pd-G3-XantPhos Precatalyst Catalysis. Molecules 23:3, pages 519.
Crossref
Crossref
Desmond O. Acheampong, Christian K. Adokoh, Du-Bois Asante, Ernest A. Asiamah, Prince A. Barnie, Dan O.M. Bonsu & Foster Kyei. (2018) Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy. Biomedicine & Pharmacotherapy 97, pages 225-232.
Crossref
Crossref
Yasuyuki Arai, Tadakazu Kondo, Akio Shigematsu, Junji Tanaka, Kazuteru Ohashi, Takahiro Fukuda, Michihiro Hidaka, Naoki Kobayashi, Koji Iwato, Toru Sakura, Makoto Onizuka, Yukiyasu Ozawa, Tetsuya Eto, Mineo Kurokawa, Kaoru Kahata, Naoyuki Uchida, Yoshiko Atsuta, Shuichi Mizuta & Shinichi Kako. (2017) Improved prognosis with additional medium‐dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults. American Journal of Hematology 93:1, pages 47-57.
Crossref
Crossref
Thi Thanh Huyen Luong, Sabrina Touchet, Mouad Alami & Samir Messaoudi. (2017)
Selective Palladium-Catalyzed Domino Heck/Buchwald-Hartwig Arylations of
N
-Glycosylcinnamamides: An Efficient Route to 4-Aryl-
N
-glycosylquinolin-2-ones
. Advanced Synthesis & Catalysis 359:8, pages 1320-1330.
Crossref
Crossref
James McCloskey, Jamie Koprivnikar, Stefan Faderl, Dirk Reinhardt & Nobuko Hijiya. 2017. Chemotherapy for Leukemia. Chemotherapy for Leukemia
287
309
.
A Desjonquères, P Chevallier, X Thomas, F Huguet, T Leguay, M Bernard, J-O Bay, E Tavernier, A Charbonnier, F Isnard, M Hunault, P Turlure, M Renaud, J-N Bastié, C Himberlin, S Lepretre, B Lioure, V Lhéritier, V Asnafi, K Beldjord, M Lafage-Pochitaloff, M C Béné, N Ifrah & H Dombret. (2016) Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study. Blood Cancer Journal 6:12, pages e504-e504.
Crossref
Crossref
Amir T. Fathi, Daniel J. DeAngelo, Kristen E. Stevenson, Jonathan E. Kolitz, Julie D. Asch, Philip C. Amrein, Eyal C. Attar, David P. Steensma, Martha Wadleigh, Julia Foster, Christine Connolly, Ilene Galinsky, Craig E. Devoe, Richard M. Stone, Donna S. Neuberg & Karen K. Ballen. (2016) Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia. Cancer 122:15, pages 2379-2388.
Crossref
Crossref
Brigitte Nelken, Helene Cave, Guy Leverger, Claire Galambrun, Genevieve Plat, Claudine Schmitt, Caroline Thomas, C?cile V?rit?, Benoit Brethon, Virginie Gandemer, Yves Bertrand, Andr? Baruchel & Pierre Rohrlich. (2016) A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee). Pediatric Blood & Cancer 63:2, pages 270-275.
Crossref
Crossref
Mark R. Litzow & Adolfo A. Ferrando. (2015) How I treat T-cell acute lymphoblastic leukemia in adults. Blood 126:7, pages 833-841.
Crossref
Crossref